These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20886906)

  • 1. Random glycopeptide bead libraries for seromic biomarker discovery.
    Kracun SK; Cló E; Clausen H; Levery SB; Jensen KJ; Blixt O
    J Proteome Res; 2010 Dec; 9(12):6705-14. PubMed ID: 20886906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-throughput O-glycopeptide discovery platform for seromic profiling.
    Blixt O; Cló E; Nudelman AS; Sørensen KK; Clausen T; Wandall HH; Livingston PO; Clausen H; Jensen KJ
    J Proteome Res; 2010 Oct; 9(10):5250-61. PubMed ID: 20726594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seromic profiling of colorectal cancer patients with novel glycopeptide microarray.
    Pedersen JW; Blixt O; Bennett EP; Tarp MA; Dar I; Mandel U; Poulsen SS; Pedersen AE; Rasmussen S; Jess P; Clausen H; Wandall HH
    Int J Cancer; 2011 Apr; 128(8):1860-71. PubMed ID: 21344374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.
    Wandall HH; Blixt O; Tarp MA; Pedersen JW; Bennett EP; Mandel U; Ragupathi G; Livingston PO; Hollingsworth MA; Taylor-Papadimitriou J; Burchell J; Clausen H
    Cancer Res; 2010 Feb; 70(4):1306-13. PubMed ID: 20124478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
    Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
    Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast epitope mapping for the anti-MUC1 monoclonal antibody by combining a one-bead-one-glycopeptide library and a microarray platform.
    Garcia-Martin F; Matsushita T; Hinou H; Nishimura S
    Chemistry; 2014 Nov; 20(48):15891-902. PubMed ID: 25303614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8).
    Steentoft C; Schjoldager KT; Cló E; Mandel U; Levery SB; Pedersen JW; Jensen K; Blixt O; Clausen H
    Glycoconj J; 2010 Aug; 27(6):571-82. PubMed ID: 20721622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
    Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
    Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplified Detection of Breast Cancer Autoantibodies Using MUC1-Based Tn Antigen Mimics.
    Guillen-Poza PA; Sánchez-Fernández EM; Artigas G; García Fernández JM; Hinou H; Ortiz Mellet C; Nishimura SI; Garcia-Martin F
    J Med Chem; 2020 Aug; 63(15):8524-8533. PubMed ID: 32672464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
    Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
    Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel Glyco-SPOT Synthesis of Glycopeptide Libraries.
    Mehta AY; Veeraiah RKH; Dutta S; Goth CK; Hanes MS; Gao C; Stavenhagen K; Kardish R; Matsumoto Y; Heimburg-Molinaro J; Boyce M; Pohl NLB; Cummings RD
    Cell Chem Biol; 2020 Sep; 27(9):1207-1219.e9. PubMed ID: 32610041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.
    Pett C; Cai H; Liu J; Palitzsch B; Schorlemer M; Hartmann S; Stergiou N; Lu M; Kunz H; Schmitt E; Westerlind U
    Chemistry; 2017 Mar; 23(16):3875-3884. PubMed ID: 27957769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated MUC1 tandem-repeat glycopeptide microarrays to evaluate serum- and monoclonal-antibody specificity.
    Westerlind U; Schröder H; Hobel A; Gaidzik N; Kaiser A; Niemeyer CM; Schmitt E; Waldmann H; Kunz H
    Angew Chem Int Ed Engl; 2009; 48(44):8263-7. PubMed ID: 19718733
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycopeptide microarray for autoantibody detection in cancer.
    Reis CA; Campos D; Osório H; Santos LL
    Expert Rev Proteomics; 2011 Aug; 8(4):435-7. PubMed ID: 21819298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic methods of glycopeptide assembly, and biological analysis of glycopeptide products.
    Meldal M; St Hilaire PM
    Curr Opin Chem Biol; 1997 Dec; 1(4):552-63. PubMed ID: 9667891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation and detection of minimal length glycopeptide neoantigen epitopes centering the GSTA region of MUC1 by liquid chromatography/mass spectrometry.
    Zhou D; Xiao K; Tian Z
    Rapid Commun Mass Spectrom; 2020 Mar; 34(6):e8622. PubMed ID: 31658499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes.
    Corzana F; Asín A; Eguskiza A; De Tomi E; Martín-Carnicero A; Martínez-Moral MP; Mangini V; Papi F; Bretón C; Oroz P; Lagartera L; Jiménez-Moreno E; Avenoza A; Busto JH; Nativi C; Asensio JL; Hurtado-Guerrero R; Peregrina JM; Malerba G; Martínez A; Fiammengo R
    Angew Chem Int Ed Engl; 2024 Sep; 63(37):e202407131. PubMed ID: 38935849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific N-glycosylation analysis: matrix-assisted laser desorption/ionization quadrupole-quadrupole time-of-flight tandem mass spectral signatures for recognition and identification of glycopeptides.
    Krokhin O; Ens W; Standing KG; Wilkins J; Perreault H
    Rapid Commun Mass Spectrom; 2004; 18(18):2020-30. PubMed ID: 15378712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.